21 May 2013
Keywords: Grifols, VCN Bioscience, Cancer treatment, M&A
Article | 16 July 2012
Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer, has acquired 40% of the equity of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 July 2012
17 July 2012
20 May 2013
© 2013 thepharmaletter.com